Brief: BIOSYNEX FY EBITDA Up At EUR 143.1 Mln

Biosynex SA

24/03/2022 17:30

March 24 (Reuters) - Biosynex SA  ALBIO.PA :
    * FY TURNOVER EUR 382.5 MILLION VERSUS EUR 153.9 MILLION
YEAR AGO
    * FY EBITDA EUR 143.1 MILLION VERSUS EUR 52.0 MILLION YEAR
AGO
    * FY NET CONSOLIDATED RESULT EUR 104.0 MILLION VERSUS EUR
31.4
MILLION YEAR AGO
    * PROPOSES DIVIDEND OF 2 EUR PER SHARE
    * WILL CONTINUE TO BENEFIT IN 2022 FROM THE CONTRIBUTION OF
SALES
OF COVID-19 PRODUCTS, BUT TO A MUCH LESSER EXTENT THAN IN 2021
    * IN 2021, GROSS MARGIN WAS €190.9 MILLION (49.9% OF
REVENUES)
COMPARED TO €81.2 MILLION (52.8% OF REVENUES) YEAR AGO

Source text for Eikon:  ID:nEQlQFkQa 
Further company coverage:  ALBIO.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))